Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children
MUSIC
1 other identifier
observational
1,200
2 countries
33
Brief Summary
Multi-system Inflammatory Syndrome in Children (MIS-C) is a new condition related to COVID-19, the study investigators are still learning about its causes, effects, and long-term impact. "Long-Term Outcomes after the Multisystem Inflammatory Syndrome In Children", the Coronavirus MUSIC Study, is a research study funded by NIH and the National Heart, Lung, and Blood Institute. The study investigators hope to enroll at least 900 young people with MIS-C at children's medical centers in the U.S. and Canada. This research study will help us learn more about MIS-C and its effects on the long-term health of children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
Longer than P75 for all trials
33 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 30, 2020
CompletedFirst Submitted
Initial submission to the registry
February 9, 2022
CompletedFirst Posted
Study publicly available on registry
March 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
March 27, 2026
March 1, 2026
5.8 years
February 9, 2022
March 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
worst-ever LV ejection fraction
worst left ventricular (LV) ejection fraction from core lab echo read during MUSIC study
hospital admission through 5 years post-hospitalization
worst-ever maximum z score of the proximal LAD or RCA
worst maximum z-score of the proximal left anterior descending coronary artery (LAD) or right coronary artery (RCA) from core lab echo read; z-scores to be calculated via Boston z-score calculator (primary) and Pediatric Heart Network z-score calculator (secondary); higher z-scores are worse
hospital admission through 5 years post-hospitalization
Secondary Outcomes (34)
Occurrence of a proximal LAD or RCA z score of ≥2.5 on any echocardiogram
hospital admission through 5 years post-hospitalization
Occurrence of aneurysms by Japanese Ministry of Health criteria
hospital admission through 5 years post-hospitalization
Individual z scores for LMCA, RCA and LAD
hospital admission through 5 years post-hospitalization
LVEDV z score
hospital admission through 5 years post-hospitalization
LVEF
hospital admission through 5 years post-hospitalization
- +29 more secondary outcomes
Eligibility Criteria
children and young adults \<21 years with Multisystem Inflammatory Syndrome in Children associated with COVID-19 (MIS-C) at a participating hospital
You may qualify if:
- Age \<21 years.
- Fever ≥38°C for ≥24 hours, or report of subjective fever lasting ≥24 hours.
- Laboratory evidence of inflammation, including, but not limited to, one or more of the following: an elevated CRP, ESR, fibrinogen, procalcitonin, d-dimer, ferritin, LDH, or IL-6, elevated neutrophils, reduced lymphocytes and low albumin.
- Evidence of clinically severe illness requiring hospitalization, with multisystem (≥2) organ involvement, based on clinical judgment from record review, discharge diagnosis, laboratory or diagnostic tests. Organ system involvement includes but is not limited to cardiac, renal, respiratory, hematologic including coagulopathy, gastrointestinal including liver, dermatologic or neurological.
- Positive for current or recent SARS-CoV-2 infection by RT-PCR, serology, or antigen test; or COVID-19 exposure within the 4 weeks prior to the onset of symptoms
You may not qualify if:
- No plausible alternative diagnosis, such as bacterial sepsis, murine typhus, staphylococcal or streptococcal shock syndromes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Carelon Researchlead
Study Sites (33)
University of Alabama
Tuscaloosa, Alabama, 35401, United States
Phoenix Children's Hospital
Phoenix, Arizona, 85016, United States
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
Valley Children's Healthcare and Hospital
Madera, California, 93636, United States
UC San Diego, Rady Children's Hospital
San Diego, California, 92131, United States
Children's Hospital of Colorado
Aurora, Colorado, 80045, United States
The Nemours Foundation
Wilmington, Delaware, 19808, United States
Children's National Hospital
Washington D.C., District of Columbia, 20010, United States
Joe DiMaggio Children's Hospital
Hollywood, Florida, 33021, United States
Nicklaus Children's Hospital
Miami, Florida, 33155, United States
Chldren's Healthcare of Atlanta
Atlanta, Georgia, 30322, United States
Ann & Robert Lurid Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
Riley Children's Hospital
Indianapolis, Indiana, 46202, United States
Children's Hospital of New Orleans
New Orleans, Louisiana, 70118, United States
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
CS Mott Children's Hospital/University of Michigan
Ann Arbor, Michigan, 48109, United States
Children's Hospital of Michigan
Detroit, Michigan, 48201, United States
University of Mississippi
Jackson, Mississippi, 39216, United States
Children's Mercy Hospital
Kansas City, Missouri, 64108, United States
Morgan Stanley Children's Hospital of New York
New York, New York, 10032, United States
Cohen Children's Medical Center
Queens, New York, 11040, United States
University of North Carolina
Chapel Hill, North Carolina, 27514, United States
Duke Children's Hospital and Health Center
Durham, North Carolina, 27705, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Dell Medical Center
Austin, Texas, 78707, United States
Children's Medical Center of Dallas - UT Southwestern Medical Center
Dallas, Texas, 75235, United States
Baylor /Texas Children's Hospital
Houston, Texas, 77030, United States
Primary Children's Hospital
Salt Lake City, Utah, 84113, United States
Seattle Children's Hospital
Seattle, Washington, 98105, United States
Medical College of Wisconsin/Children's Hospital of Wisconsin
Milwaukee, Wisconsin, 53226, United States
The Hospital for Sick Children
Toronto, Ontario, Canada
Related Publications (1)
Lang SM, Truong DT, Powell AJ, Kazlova V, Newburger JW, Awerbach JD, Binka E, Bradford TT, Cartoski M, Cheng A, DiLorenzo MP, Dionne A, Dorfman AL, Elias MD, Garuba O, Gerardin JF, Hasbani K, Jone PN, Lam CZ, Misra N, Morgan LM, Nutting A, Patel JK, Robinson JD, Schuchardt EL, Sexson Tejtel K, Singh GK, Slesnick TC, Trachtenberg F, Taylor MD; MUSIC Study Investigators. CMR Findings in the Long-Term Outcomes After Multisystem Inflammatory Syndrome in Children (MUSIC) Study. Circ Cardiovasc Imaging. 2025 Sep;18(9):e017420. doi: 10.1161/CIRCIMAGING.124.017420. Epub 2025 Apr 4.
PMID: 40181776DERIVED
Biospecimen
Blood or saliva that is collected for future whole genome sequencing will be requested as optional at any time that the patient is undergoing a clinical laboratory draw in participants who provide consent for this testing. To better understand the genetic variation within the heterogenous MIS-C population, blood or saliva samples from the biological parents of MIS-C patients will also be requested as optional. Samples from parents will also be stored at the similar venue for future whole genome sequencing. In addition, the study investigators expect to collaborate with centers or networks that are collecting research samples on these patients.
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2022
First Posted
March 18, 2022
Study Start
September 30, 2020
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
March 27, 2026
Record last verified: 2026-03